Korean Journal of Microbiology (미생물학회지)

The Microbiological Society of Korea (한국미생물학회)
권호 표지
DOI QR코드

DOI QR Code

Isolation and Characterization of Bacillus subtilis MP56 with Antimicrobial Activity against MDR (Multi Drug Resistant) Strains

다약제내성균에 대한 항균 활성을 가지는 Bacillus subtilis MP56 균주의 분리 및 특성분석

  • Park, Sungyong (Department of Pharmacy, College of Pharmacy, Mokpo National University) ;
  • Yoo, Jincheol (Department of Pharmacy, College of Pharmacy, Chosun University) ;
  • Seong, Chinam (Department of Biology, College of Natural Sciences, Sunchon National University) ;
  • Cho, Seungsik (Department of Pharmacy, College of Pharmacy, Mokpo National University)
  • Received : 2013.02.22
  • Accepted : 2013.03.22
  • Published : 2013.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

A new Bacillus strain designated as MP56 producing antimicrobial substance has been isolated from the mud flat of Korea. The strain MP56 was found to exhibit broad spectrum of antimicrobial activity against Gram-positive pathogenic microorganisms and MDR (multi drug resistant) strains. The 16S rRNA sequence revealed that the MP56 was closely related to Bacillus subtilis with 99.93% homology. The optimal medium composition for production of antimicrobial substance in the B. subtilis MP56 were 1% mannitol, 1% oat meal, 0.01% $CaCl_2$. Antimicrobial activity of the culture broth against different pathogenic strains was assessed using the antimicrobial spectrum. The result suggests that Bacillus strain MP56 produces high quality antimicrobial substance that might be very useful to control varieties of pathogenic microbial growth.

최근 국내외로 MRSA, VRE 등의 다약제 내성 균주의 분리빈도가 매년 급증하고 있고, 시판하고 있는 항생제 중 가장 효능이 강력한 제품들도 다약제 내성균 출현율이 증가함에 따라 이를 극복할 새로운 항생제의 개발이 요구되고 있다. 다약제 내성균에 유효한 항생제의 예로 vancomycin, teicoplanin, linezolid가 다약제 내성균에 유효한 의약품으로 쓰이고 있으며 방선균이나 Bacillus 등의 배양액에서 다약제 내성균에 유효한 물질의 발굴에 대한 연구가 활발히 진행되고 있다. 특히 넓은 항균범위를 가지고, 체내 축척이 적은 항생물질에 개발에 대한 연구가 활발히 진행되고 있다. 본 연구진은 국내 서해안의 갯벌에서 Bacillus 속 미생물을 수종 분리하였으며, 다약제 내성균에 항균 활성을 지니는 MP56 균주를 선발하였고, 균주 동정 결과 Bacillus subtilis 와 99.93%의 16S rRNA 상동성을 나타냄을 본 연구에서 확인하였다. 국내외 연구진에 의하여 다수의 Bacillus 속 미생물이 분리된 바가 있으며, 항균 물질에 대한 연구도 보고된 바 있다. 그러나 국내 갯벌에서 분리된 Bacillus 속 균주 배양액의 임상균주에 대한 항균 효능 평가에 관한 연구는 보고된 바가 없다. 본 연구에서 Bacillus 속 균주 MP56 배양액이 국내에서 분리한 임상 균주인 MRSA, IMP 균주에 대해 우수한 항균 활성을 나타내어 최적 발효조건과 항균범위를 본 논문을 통해 보고하였으며, 추후 MP56 균주 배양액에서 항균물질의 분리, 정제 및 구조 규명을 위한 후속 연구를 수행 할 예정이다.

Keywords

References

  1. Alanis, A.J. 2005. Resistance to antibiotics: Are we in the post-antibiotic era? Arch. Med. Res. 36, 697-705. https://doi.org/10.1016/j.arcmed.2005.06.009
  2. Aunpad, R. and Na-Bangchang, K. 2007. Pumilicin 4, a novel bacteriocin with anti-MRSA and anti-VRE activity produced by newly isolated bacteria Bacillus pumilus strain WAPB4. Curr. Microbiol. 55, 308-313. https://doi.org/10.1007/s00284-006-0632-2
  3. Chang, H.C. and Yang, E.J. 2007. Characterization of bacteriocin-like substances produced by Bacillus subtilis MJP1. Kor. J. Microbiol. Biotechnol. 35, 339-346.
  4. Choi, Y.H., Cho, S.S., Simkhada, J.R., and Yoo, J.C. 2012. A novel thermotolerant and acidotolerant peptide produced by a Bacillus strain newly isolated from a fermented food (kimchi) shows activity against multidrug-resistant bacteria. Int. J. Antimicrob. 40, 80-83. https://doi.org/10.1016/j.ijantimicag.2012.03.019
  5. Delcambe, L. 1950. Iturine, new antibiotic produced by Bacillus subtilis. C R Seances. Soc. Biol. Fil. 144, 1431-1434.
  6. Drago, L., Nicola, L., and De Vecchi, E. 2008. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp. Clin. Microbiol. Infect. 14, 608-611. https://doi.org/10.1111/j.1469-0691.2008.01993.x
  7. Felsenstein, J. 1985. Confidence limits on phylogenies: An approach using the bootstrap. Evolution 39, 783-791. https://doi.org/10.2307/2408678
  8. Hashizume, H. 2012. Studies for the development of novel anti-MRSA/VRE drugs. Yakugaku zasshi : J. Pharm. Soc. Jap. 132, 59-67. https://doi.org/10.1248/yakushi.132.59
  9. Jukes, T.H.a.C.R.C. 1969. Evolution of protein molecules. Mammalian protein metabolism, pp. 21-132. In Munro, H.N. (ed.). Academic Press, New York, N.Y., USA.
  10. Kim, D.H., Kang, K.R., Kim, H.W., Yoon, S.Y., Kim, C.G., Yamaguchi, T., Sohng, J.K., and Kang, J.S. 2010. Structure determination of macrolactin compounds with antibacterial activities isolated from Bacillus polyfermenticus KJS-2. J. Life Sci. 20, 1792-1800. https://doi.org/10.5352/JLS.2010.20.12.1792
  11. Klein, C., Kaletta, C., and Entian, K.D. 1993. Biosynthesis of the lantibiotic subtilin is regulated by a histidine kinase/response regulator system. Appl. Environ. Microbiol. 59, 296-303.
  12. Kluge, B., Vater, J., Salnikow, J., and Eckart, K. 1988. Studies on the biosynthesis of surfactin, a lipopeptide antibiotic from Bacillus subtilis ATCC 21332. FEBS Lett. 231, 107-110. https://doi.org/10.1016/0014-5793(88)80712-9
  13. Long, K.S. and Vester, B. 2012. Resistance to linezolid caused by modifications at its binding site on the ribosome. Antimicrob. Agents Chemother. 56, 603-612. https://doi.org/10.1128/AAC.05702-11
  14. Moshafi, M.H., Forootanfar, H., Ameri, A., Ameri, A., Shakibaie, M., Dehghan-Noudeh, G., and Razavi, M. 2011. Antimicrobial activity of Bacillus sp. strain FAS1 isolated from soil. Pak. J. Pharm. Sci. 24, 269-275.
  15. Nakano, M.M. and Zuber, P. 1990. Molecular biology of antibiotic production in Bacillus. Crit. Rev. Biotechnol. 10, 223-240. https://doi.org/10.3109/07388559009038209
  16. Saitou, N. and Nei, M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4, 406-425.
  17. Seo, D.C., Ko, J.A., Gal, S.W., and Lee, S.W. 2010. Characterization of Bacillus lichemiformis KJ-9 isolated from soil. J. Life Sci. 20, 403-410. https://doi.org/10.5352/JLS.2010.20.3.403
  18. Toama, M.A., Issa, A.A., and Ashour, M.S. 1978. Effect of agar percentage, agar thickness, and medium constituents on antibiotics assay by disc diffusion method. Pharmazie 33, 100-102.
  19. Turos, E., Long, T.E., Konaklieva, M.I., Coates, C., Shim, J.Y., Dickey, S., Lim, D.V., and Cannons, A. 2002. N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus. Bioorg. Med. Chem. Lett. 12, 2229-2231. https://doi.org/10.1016/S0960-894X(02)00343-8
  20. Woodford, N., Warner, M., and Aucken, H.M. 2000. Vancomycin resistance among epidemic strains of methicillin-resistant Staphylococcus aureus in England and wales. J. Antimicrob. Chemother. 45, 258-259. https://doi.org/10.1093/jac/45.2.258
  21. Yoo, H.S., Sohn, M.E., Cho, S.J., Park, S.K., and Lee, S.W. 2007. Characterization of antibacterial substance-producing Bacillus subtilis isolated from traditional Doenjang. J. Kor. Soc. Appl. Biol. Chem. 50, 87-94.

Cited by

  1. Screening of Non-Biogenic-Amine-Producing Bacillus subtilis and Medium Optimization for Improving Biomass by the Response Surface Methodology vol.26, pp.5, 2016, https://doi.org/10.5352/JLS.2016.26.5.571
  2. Selection and Characterization ofCheonggukjang(Fast Fermented Soybean Paste)-Originated Bacterial Strains with a High Level of S-adenosyl-L-methionine Production and Probiotics Efficacy vol.17, pp.11, 2014, https://doi.org/10.1089/jmf.2013.3052